PDB Short entry for 4CSJ HEADER SIGNALING PROTEIN 07-MAR-14 4CSJ TITLE THE DISCOVERY OF POTENT SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS, TITLE 2 SUITABLE FOR INHALATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 500-777; COMPND 5 SYNONYM: GR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 741-753; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 15 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS SIGNALING PROTEIN, NUCLEAR HORMONE RECEPTOR, LIGAND COMPLEX, PEPTIDE KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.EDMAN,R.AHLGREN,M.BENGTSSON,H.BLADH,S.BACKSTROM,J.DAHMEN, AUTHOR 2 K.HENRIKSSON,P.HILLERTZ,V.HULIKAL,A.JERRE,L.KINCHIN,C.KASE, AUTHOR 3 M.LEPISTO,I.MILE,S.NILSSON,A.SMAILAGIC,J.TAYLOR,A.TJORNEBO, AUTHOR 4 L.WISSLER,T.HANSSON REVDAT 3 20-DEC-23 4CSJ 1 REMARK REVDAT 2 21-MAY-14 4CSJ 1 JRNL REVDAT 1 07-MAY-14 4CSJ 0 JRNL AUTH K.EDMAN,R.AHLGREN,M.BENGTSSON,H.BLADH,S.BACKSTROM,J.DAHMEN, JRNL AUTH 2 K.HENRIKSSON,P.HILLERTZ,V.HULIKAL,A.JERRE,L.KINCHIN,C.KASE, JRNL AUTH 3 M.LEPISTO,I.MILE,S.NILSSON,A.SMAILAGIC,J.TAYLOR,A.TJORNEBO, JRNL AUTH 4 L.WISSLER,T.HANSSON JRNL TITL THE DISCOVERY OF POTENT AND SELECTIVE NON-STEROIDAL JRNL TITL 2 GLUCOCORTICOID RECEPTOR MODULATORS, SUITABLE FOR INHALATION. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 2571 2014 JRNL REFN ISSN 0960-894X JRNL PMID 24755427 JRNL DOI 10.1016/J.BMCL.2014.03.070 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 19758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1015 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2844 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2971 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2689 REMARK 3 BIN R VALUE (WORKING SET) : 0.2958 REMARK 3 BIN FREE R VALUE : 0.3202 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.45 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 155 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2126 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.87750 REMARK 3 B22 (A**2) : -6.87750 REMARK 3 B33 (A**2) : 13.75500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.303 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.237 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.183 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.231 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.182 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2221 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3003 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 787 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 57 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 308 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2221 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 279 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2719 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.67 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 500-529 ARE DISORDERED REMARK 4 REMARK 4 4CSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1290059905. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-06 REMARK 200 TEMPERATURE (KELVIN) : 287 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19850 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 42.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1M2Z REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG8000, 20% ETHYLENE GLYCOL AND REMARK 280 0.1 M HEPES PH7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.44600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.22300 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.22300 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 70.44600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 498 REMARK 465 SER A 499 REMARK 465 ILE A 500 REMARK 465 GLN A 501 REMARK 465 GLN A 502 REMARK 465 ALA A 503 REMARK 465 THR A 504 REMARK 465 THR A 505 REMARK 465 GLY A 506 REMARK 465 VAL A 507 REMARK 465 SER A 508 REMARK 465 GLN A 509 REMARK 465 GLU A 510 REMARK 465 THR A 511 REMARK 465 SER A 512 REMARK 465 GLU A 513 REMARK 465 ASN A 514 REMARK 465 PRO A 515 REMARK 465 GLY A 516 REMARK 465 ASP A 517 REMARK 465 LYS A 518 REMARK 465 THR A 519 REMARK 465 ILE A 520 REMARK 465 VAL A 521 REMARK 465 PRO A 522 REMARK 465 ALA A 523 REMARK 465 THR A 524 REMARK 465 LEU A 525 REMARK 465 PRO A 526 REMARK 465 GLN A 527 REMARK 465 LEU A 528 REMARK 465 THR A 529 REMARK 465 LYS A 777 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 618 -69.21 -157.03 REMARK 500 LEU A 627 82.47 -155.27 REMARK 500 ASP A 638 -3.96 69.49 REMARK 500 SER A 682 48.15 -105.74 REMARK 500 ASN A 707 136.70 -173.80 REMARK 500 ASN B 742 58.08 -98.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2071 DISTANCE = 5.98 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1777 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NN7 A 1778 REMARK 999 REMARK 999 SEQUENCE REMARK 999 PROTEIN INCLUDES STABILISING MUTANTS. DBREF 4CSJ A 500 777 UNP P04150 GCR_HUMAN 500 777 DBREF 4CSJ B 741 753 UNP E7EWM1 E7EWM1_HUMAN 741 753 SEQADV 4CSJ GLY A 498 UNP P04150 EXPRESSION TAG SEQADV 4CSJ SER A 499 UNP P04150 EXPRESSION TAG SEQADV 4CSJ ASP A 517 UNP P04150 ASN 517 ENGINEERED MUTATION SEQADV 4CSJ MET A 571 UNP P04150 VAL 571 ENGINEERED MUTATION SEQADV 4CSJ SER A 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQADV 4CSJ ASP A 638 UNP P04150 CYS 638 ENGINEERED MUTATION SEQRES 1 A 280 GLY SER ILE GLN GLN ALA THR THR GLY VAL SER GLN GLU SEQRES 2 A 280 THR SER GLU ASN PRO GLY ASP LYS THR ILE VAL PRO ALA SEQRES 3 A 280 THR LEU PRO GLN LEU THR PRO THR LEU VAL SER LEU LEU SEQRES 4 A 280 GLU VAL ILE GLU PRO GLU VAL LEU TYR ALA GLY TYR ASP SEQRES 5 A 280 SER SER VAL PRO ASP SER THR TRP ARG ILE MET THR THR SEQRES 6 A 280 LEU ASN MET LEU GLY GLY ARG GLN MET ILE ALA ALA VAL SEQRES 7 A 280 LYS TRP ALA LYS ALA ILE PRO GLY PHE ARG ASN LEU HIS SEQRES 8 A 280 LEU ASP ASP GLN MET THR LEU LEU GLN TYR SER TRP MET SEQRES 9 A 280 SER LEU MET ALA PHE ALA LEU GLY TRP ARG SER TYR ARG SEQRES 10 A 280 GLN SER SER ALA ASN LEU LEU CYS PHE ALA PRO ASP LEU SEQRES 11 A 280 ILE ILE ASN GLU GLN ARG MET THR LEU PRO ASP MET TYR SEQRES 12 A 280 ASP GLN CYS LYS HIS MET LEU TYR VAL SER SER GLU LEU SEQRES 13 A 280 HIS ARG LEU GLN VAL SER TYR GLU GLU TYR LEU CYS MET SEQRES 14 A 280 LYS THR LEU LEU LEU LEU SER SER VAL PRO LYS ASP GLY SEQRES 15 A 280 LEU LYS SER GLN GLU LEU PHE ASP GLU ILE ARG MET THR SEQRES 16 A 280 TYR ILE LYS GLU LEU GLY LYS ALA ILE VAL LYS ARG GLU SEQRES 17 A 280 GLY ASN SER SER GLN ASN TRP GLN ARG PHE TYR GLN LEU SEQRES 18 A 280 THR LYS LEU LEU ASP SER MET HIS GLU VAL VAL GLU ASN SEQRES 19 A 280 LEU LEU ASN TYR CYS PHE GLN THR PHE LEU ASP LYS THR SEQRES 20 A 280 MET SER ILE GLU PHE PRO GLU MET LEU ALA GLU ILE ILE SEQRES 21 A 280 THR ASN GLN ILE PRO LYS TYR SER ASN GLY ASN ILE LYS SEQRES 22 A 280 LYS LEU LEU PHE HIS GLN LYS SEQRES 1 B 13 GLU ASN ALA LEU LEU ARG TYR LEU LEU ASP LYS ASP ASP HET EDO A1777 4 HET NN7 A1778 33 HETNAM EDO 1,2-ETHANEDIOL HETNAM NN7 N-[(2S)-1-[[1-(4-FLUOROPHENYL)INDAZOL-4- HETNAM 2 NN7 YL]AMINO]PROPAN-2-YL]-2,4,6-TRIMETHYL- HETNAM 3 NN7 BENZENESULFONAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO C2 H6 O2 FORMUL 4 NN7 C25 H27 F N4 O2 S FORMUL 5 HOH *99(H2 O) HELIX 1 1 THR A 531 ILE A 539 1 9 HELIX 2 2 SER A 555 ALA A 580 1 26 HELIX 3 3 GLY A 583 LEU A 587 5 5 HELIX 4 4 HIS A 588 SER A 616 1 29 HELIX 5 5 GLN A 632 LEU A 636 5 5 HELIX 6 6 ASP A 638 LEU A 656 1 19 HELIX 7 7 SER A 659 LEU A 672 1 14 HELIX 8 8 SER A 682 LYS A 703 1 22 HELIX 9 9 SER A 708 ASP A 742 1 35 HELIX 10 10 LYS A 743 SER A 746 5 4 HELIX 11 11 PRO A 750 ASN A 766 1 17 HELIX 12 12 ASN B 742 LYS B 751 1 10 SHEET 1 AA 2 LEU A 621 ALA A 624 0 SHEET 2 AA 2 LEU A 627 ILE A 629 -1 O LEU A 627 N ALA A 624 SHEET 1 AB 2 SER A 674 VAL A 675 0 SHEET 2 AB 2 LYS A 770 LYS A 771 -1 O LYS A 770 N VAL A 675 CISPEP 1 SER A 616 SER A 617 0 0.19 CISPEP 2 ALA A 618 ASN A 619 0 -2.34 CISPEP 3 GLU A 705 GLY A 706 0 0.08 CISPEP 4 GLY A 706 ASN A 707 0 1.39 CISPEP 5 ASN A 707 SER A 708 0 -4.32 SITE 1 AC1 7 PRO A 541 ALA A 574 TRP A 577 LYS A 667 SITE 2 AC1 7 HOH A2030 HOH A2096 HOH A2097 SITE 1 AC2 16 LEU A 563 ASN A 564 LEU A 566 GLY A 567 SITE 2 AC2 16 GLN A 570 MET A 601 MET A 604 ALA A 607 SITE 3 AC2 16 LEU A 608 ARG A 611 PHE A 623 GLN A 642 SITE 4 AC2 16 MET A 646 CYS A 736 LEU A 753 HOH A2023 CRYST1 84.354 84.354 105.669 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011855 0.006844 0.000000 0.00000 SCALE2 0.000000 0.013689 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009464 0.00000